IP Verse

Enhancing The Effect Of Car-Engineered T Cells By Means Of Nucleic Acid Vaccination - EP3294325

The patent EP3294325 was granted to Biontech Cell&Gene Therapies on Jul 26, 2023. The application was originally filed on May 9, 2016 under application number EP16724861A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3294325

BIONTECH CELL&GENE THERAPIES
Application Number
EP16724861A
Filing Date
May 9, 2016
Status
Granted And Under Opposition
Jun 23, 2023
Grant Date
Jul 26, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

WITHERS & ROGERSApr 25, 2024TOMBLINGADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONUS2003118592
DESCRIPTIONUS2003133939
DESCRIPTIONWO2013143683
INTERNATIONAL-SEARCH-REPORTUS2014099340
INTERNATIONAL-SEARCH-REPORTWO2014144622
INTERNATIONAL-SEARCH-REPORTWO2015150327
OPPOSITIONWO2013143683
OPPOSITIONWO2015150327
OPPOSITIONWO2016180778

Non-Patent Literature (NPL) Citations (12) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- S. Holtkamp ET AL, "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells", Blood, (20061215), vol. 108, no. 13, doi:10.1182/blood-2006-04-015024, ISSN 0006-4971, pages 4009 - 4017, XP055044965
EXAMINATION- Hui-Rong Jiang ET AL, "Combination of Vaccination and Chimeric Receptor Expressing T Cells Provides Improved Active Therapy of Tumors", JOURNAL OF IMMUNOLOGY, (20061001), vol. 177, no. 7, doi:10.4049/jimmunol.177.7.4288, pages 4288 - 4298, XP055184895
OPPOSITION- Kalos Michael , June Carl H, "Adoptive T Cell Transfer for Cancer Immunotherapy in the Era of Synthetic Biology", Immunity, AMSTERDAM, NL , (20130725), vol. 39, no. 1, doi:10.1016/j.immuni.2013.07.002, ISSN 1074-7613, pages 49 - 60, XP002734273
OPPOSITION- Jessica B Foster; David M Barrett; Katalin Karikó, "The Emerging Role of In Vitro-Transcribed mRNA in Adoptive T Cell Immunotherapy", Molecular Therapy, US , (20190401), vol. 27, no. 4, doi:10.1016/j.ymthe.2019.01.018, ISSN 1525-0016, pages 747 - 756, XP055723869
OPPOSITION- J. Saenz‐Badillos; S. P. Amin; R. D. Granstein, "RNA as a tumor vaccine: a review of the literature", Experimental dermatology, COPENHAGEN; DK , (20011221), vol. 10, no. 3, doi:10.1034/j.1600-0625.2001.010003143.x, ISSN 0906-6705, pages 143 - 154, XP071775335
OPPOSITION- Michael H. Kershaw, Jennifer A. Westwood, Phillip K. Darcy, "Gene-engineered T cells for cancer therapy", Nature Reviews Cancer, London , (20130801), vol. 13, no. 8, doi:10.1038/nrc3565, ISSN 1474-175X, pages 525 - 541, XP055543320
OPPOSITION- Sahin Ugur; Karikó Katalin; Türeci Özlem, "mRNA-based therapeutics — developing a new class of drugs", Nature Reviews Drug Discovery, GB , (20140919), vol. 13, no. 10, doi:10.1038/nrd4278, ISSN 1474-1776, pages 759 - 780, XP037134862
OPPOSITION- R W Malone, P L Felgner, I M Verma, "Cationic liposome-mediated RNA transfection", Proceedings of the National Academy of Sciences, (19890801), vol. 86, no. 16, doi:10.1073/pnas.86.16.6077, ISSN 0027-8424, pages 6077 - 6081., XP000604642
OPPOSITION- Martin A. Cheever; Wei Chen, "Therapy with cultured T cells: principles revisited", Immunological Reviews, US , (20081009), vol. 157, no. 1, doi:10.1111/j.1600-065X.1997.tb00982.x, ISSN 0105-2896, pages 177 - 194, XP071454051
OPPOSITION- S. Holtkamp, S. Kreiter, A. Selmi, P. Simon, M. Koslowski, C. Huber, O. Tureci, U. Sahin, "Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells", Blood, (20061215), vol. 108, no. 13, doi:10.1182/blood-2006-04-015024, ISSN 0006-4971, pages 4009 - 4017, XP055044965
OPPOSITION- Patrick Midoux, Pichon Chantal, "Lipid-based mRNA vaccine delivery systems", Expert review of vaccines, GB , (20150212), vol. 14, no. 2, doi:10.1586/14760584.2015.986104, ISSN 1476-0584, pages 221 - 234, XP055439935
OPPOSITION- Hui-Rong Jiang, Gilham David E, Mulryan Kate, Kirillova Natalia, Hawkins Robert E, Stern Peter L, "Combination of Vaccination and Chimeric Receptor Expressing T Cells Provides Improved Active Therapy of Tumors ", The Journal of Immunology, (20061001), vol. 177, no. 7, doi:10.4049/jimmunol.177.7.4288, pages 4288 - 4298, XP055184895

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents